Behavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue.
暂无分享,去创建一个
[1] A Scott,et al. Support of thyroxine-induced swelling of liver mitochondria by generation of high energy intermediates at any one of three sites in electron transport. , 1966, The Journal of biological chemistry.
[2] W. Clark,et al. Studies on Oxidation-Reduction: VIII. Methylene Blue , 1925 .
[3] F Gonzalez-Lima,et al. Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. , 2005, European journal of pharmacology.
[4] F. Guimarães,et al. Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[5] F Gonzalez-Lima,et al. Extinction memory improvement by the metabolic enhancer methylene blue. , 2004, Learning & memory.
[6] C. Agnisola,et al. Evidence for NO-dependent vasodilation in the trout (Oncorhynchus mykiss ) coronary system , 1997, Journal of Comparative Physiology B.
[7] A. Weinbroum,et al. Methylene blue attenuates lung injury after mesenteric artery clamping/unclamping , 2004, European journal of clinical investigation.
[8] M. Kelner,et al. Potential of methylene blue to block oxygen radical generation in reperfusion injury. , 1988, Basic life sciences.
[9] M. Wainwright,et al. Methylene Blue - a Therapeutic Dye for All Seasons? , 2002, Journal of chemotherapy.
[10] M. Pfaffendorf,et al. The interaction between methylene blue and the cholinergic system , 1997, British journal of pharmacology.
[11] J. Leikin,et al. Methylene blue , 2021, ASHP® Injectable Drug Information™.
[12] A. Pakarinen,et al. Effects of Drugs on Clinical Laboratory Tests , 1997, Annals of clinical biochemistry.
[13] C. Babbs,et al. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. , 1991, Biochemical pharmacology.
[14] G. Burrows. Methylene blue: effects and disposition in sheep. , 1984, Journal of veterinary pharmacology and therapeutics.
[15] C. Dawson,et al. Reduction of thiazine dyes by bovine pulmonary arterial endothelial cells in culture. , 1995, The American journal of physiology.
[16] F. Gonzalez-Lima,et al. Methylene blue improves brain oxidative metabolism and memory retention in rats , 2004, Pharmacology Biochemistry and Behavior.
[17] J. Stucki,et al. Stimulation of respiration by methylene blue in rat liver mitochondria , 1997, FEBS letters.
[18] D. Santani,et al. A novel use of methylene blue as a pharmacological tool. , 2006, Journal of pharmacological and toxicological methods.
[19] B. Mayer,et al. Novel actions of methylene blue. , 1993, European heart journal.
[20] C. E. Cobb,et al. Reduction and uptake of methylene blue by human erythrocytes. , 2004, American journal of physiology. Cell physiology.
[21] P. Gillman,et al. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction , 2007, British journal of pharmacology.
[22] A. Sidi,et al. Blue dyes, blue people: the systemic effects of blue dyes when administered via different routes. , 2007, Journal of clinical anesthesia.
[23] M. Roth,et al. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Wong-Riley. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity , 1989, Trends in Neurosciences.
[25] F. Gonzalez-Lima,et al. Methylene blue prevents neurodegeneration caused by rotenone in the retina , 2009, Neurotoxicity Research.
[26] J. Cragan. Teratogen update: methylene blue. , 1999, Teratology.
[27] Takeshi Iwatsubo,et al. Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins* , 2005, Journal of Biological Chemistry.
[28] G. Dawson,et al. Use of the elevated plus maze in the search for novel anxiolytic agents. , 1995, Trends in pharmacological sciences.
[29] David L. McCollum,et al. Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats , 2002, Neuroscience Letters.
[30] A. Szold,et al. Methylene Blue in Preventing Hemodynamic and Metabolic Derangement Following Superior Mesenteric Artery Clamping/Unclamping: An Intratracheal vs. Intraperitoneal Dose-Response Study , 2002, Shock.
[31] Kathleen A. Boyle,et al. Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] L. Eroǧlu,et al. Anxiolytic and antidepressant properties of methylene blue in animal models. , 1997, Pharmacological research.
[33] Edward J Calabrese,et al. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. , 2007, Toxicology and applied pharmacology.
[34] D. Young,et al. Effects of drugs on clinical laboratory tests. , 1972, Clinical chemistry.
[35] D. Schrijvers,et al. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature , 2000, British Journal of Cancer.
[36] James L. McGaugh,et al. Methylene blue alters retention of inhibitory avoidance responses , 1978 .
[37] L. Breydo,et al. Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. , 2007, Biochemistry.
[38] P. Rosenberg,et al. Methylene blue adjuvant therapy of schizophrenia. , 1997, Clinical neuropharmacology.
[39] G. Naylor,et al. A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manicdepressive psychosis , 1986, Biological Psychiatry.